[Use of glucose solutions in the prevention and treatment of fetal hypoxia].
D000138:Acidosis / Q000209:etiology; D000818:Animals; D001205:Ascorbic Acid / Q000008:administration & dosage; D001786:Blood Glucose / Q000032:analysis; D001921:Brain / Q000378:metabolism; D004285:Dogs; D004359:Drug Therapy, Combination; D005314:Embryonic and Fetal Development / Q000187:drug effects; D005260:Female; D005312:Fetal Blood / Q000032:analysis; D005317:Fetal Growth Retardation / Q000517:prevention & control; D005311:Fetal Hypoxia / Q000517:prevention & control* / Q000628:therapy; D005947:Glucose / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007328:Insulin / Q000008:administration & dosage / Q000378:metabolism; D000078790:Insulin Secretion; D008320:Maltose / Q000627:therapeutic use; D008431:Maternal-Fetal Exchange; D010102:Oxygen Inhalation Therapy / Q000009:adverse effects; D010920:Placenta / Q000502:physiology; D010928:Placental Lactogen / Q000032:analysis; D011247:Pregnancy; D012756:Sheep; D013835:Thiamine Pyrophosphate / Q000008:administration & dosage
D001786:Blood Glucose; D007328:Insulin; D008320:Maltose; D010928:Placental Lactogen; D005947:Glucose; D001205:Ascorbic Acid; D013835:Thiamine Pyrophosphate
Primenenie rastvorov gliukozy dlia profilaktiki i lecheniia gipoksii ploda.